Context Global health crises are on the rise, especially those caused by infectious disease outbreaks, and pose a serious threat to health and well-being. WHO estimates that up to 10 million lives could be saved every year if access to safe and effective medicines and vaccines were improved. As a…
Context Vaccines remain the most effective tool for preventing infectious diseases and for improving global health. As only 1% of the vaccines needed in Africa are currently produced in Africa, the continent needs a robust vaccine industry. The COVID-19 pandemic, in particular, has highlighted the need for supranational structures to…
Context The Ebola epidemic and the COVID-19 pandemic have clearly demonstrated that timely access to safe, effective and affordable medicines and vaccines is vital to prevent and fight infectious diseases and protect public health. Many African countries, however, rely on imports of vaccines because national production capacity is insufficient and…
Short Description Compared to other regions in the world, the African continent is faced with a particularly high number of infectious diseases. These include acute fevers of unknown origin as well as anti-infective-resistant pathogens that have barely been examined to date. This demonstrates a significant shortcoming, as illustrated by the…
Short Description Few countries in Sub-Saharan Africa have surveillance systems for antimicrobial resistance (AMR), resulting in significant gaps in data pertaining to bacteria of public health relevance. In cooperation with TRICE, this project aims to enhance resistance diagnostics in project countries by introducing a blood culture diagnostic system. Aims of…
Due to current COVID-19 related travel restrictions, the kickoff workshop of the PharmTrain-CoronaGlobal (PT-CoronaGlobal) project took place as an online event from 27 September to 29 September 2021. In collaboration with the Southern African Development Community (SADC) and the African Union Development Agency (AUDA-NEPAD), the project aims to strengthen the…
During a six weeks-stay (30 January – 15 March 2021), Paul Pitzinger from RKI (P3) visited the partner sites in both Côte d’Ivoire and Burkina Faso. One aim of the visit was to support our partners in SARS-CoV-2 diagnostics in particular technical support in serological SARS-CoV-2 analyses. Another aim…
Within the scope of ANDEMIA a course in „Advanced Epidemiology and Statistics“ was held at the National Institute for Communicable Diseases (NICD) in Johannesburg from 7 to 23 of May 2019. The course was taught by Dr. Matthias Borchert (RKI Berlin). Overall 14 participants from the Democratic Republic of Congo,…
Due to the current global pandemic, the GHPP projects TRICE and ARGOS have set themselves the task of providing the best possible support to our partner countries (Ivory Coast, Burkina Faso, Democratic Republic of Congo and South Africa) and several other institutions in other African countries (Central African Republic, Zambia,…